News stories about Burcon NutraScience Corp (NASDAQ:BUR) (TSE:BU) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Burcon NutraScience Corp earned a daily sentiment score of 0.24 on Accern’s scale. Accern also assigned media coverage about the biotechnology company an impact score of 44.7122773295495 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Separately, ValuEngine downgraded Burcon NutraScience Corp from a “sell” rating to a “strong sell” rating in a research note on Thursday, July 20th.
Shares of Burcon NutraScience Corp (NASDAQ BUR) remained flat at $0.89 during trading on Friday. The company’s stock had a trading volume of 100 shares. The stock’s market cap is $33.67 million. Burcon NutraScience Corp has a 1-year low of $0.77 and a 1-year high of $2.86. The stock’s 50-day moving average price is $1.04 and its 200 day moving average price is $1.40.
Burcon NutraScience Corp Company Profile
Burcon NutraScience Corp (Burcon) is a Canada-based company, which is engaged in development of functional and renewable plant proteins. The Company has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology. The Company and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates.
Receive News & Ratings for Burcon NutraScience Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon NutraScience Corp and related companies with MarketBeat.com's FREE daily email newsletter.
